Physician pay-for-performance. Implementation and research issues.

Journal of General Internal Medicine
Jon B ChristiansonRoger S Mazze

Abstract

Recent research underscores the gaps that exist between evidence-based medical practices and the care that many patients actually receive. Recognizing this, large purchasers are experimenting with new reimbursement arrangements called pay-for-performance (P4P) that tie a portion of payments for physician services to measures of quality. Agency theory, from the discipline of economics, provides a perspective on the challenges P4P is likely to encounter. The focus of most P4P initiatives on medical group performance raises additional questions about its potential effectiveness as a catalyst for change.

References

Feb 9, 1999·American Journal of Public Health·G FairbrotherG C Butts
Feb 19, 1999·BMJ : British Medical Journal·S H WoolfJ Grimshaw
Jun 15, 1999·JAMA : the Journal of the American Medical Association·T P HoferW G Manning
Oct 8, 1999·The New England Journal of Medicine·L P Casalino
Oct 27, 1999·JAMA : the Journal of the American Medical Association·M D CabanaH R Rubin
Mar 29, 2000·Journal of Pediatric Health Care : Official Publication of National Association of Pediatric Nurse Associates & Practitioners·D H Havens, L Boroughs
Jul 7, 2001·The Milbank Quarterly·J C Robinson
Jan 5, 2002·Journal of Health Politics, Policy and Law·L Casalino
Apr 17, 2003·JAMA : the Journal of the American Medical Association·Donald M Berwick
Jun 27, 2003·The New England Journal of Medicine·Elizabeth A McGlynnEve A Kerr
Oct 2, 2003·Genome Biology·Gregory A Petsko
Dec 4, 2003·The Journal of the American Board of Family Practice·Ann CuroeAmer Kaissi
Dec 3, 2003·Health Affairs·Donald M BerwickGail R Wilensky
Dec 31, 2003·Osteoarthritis and Cartilage·Eric P Vignon, Larry Moreland
Mar 30, 2004·Health Affairs·Meredith B RosenthalBruce Landon
Jun 24, 2004·American Journal of Preventive Medicine·Catherine Kim, Gloria L Beckles
Jul 29, 2004·Joint Commission Journal on Quality and Safety·Sumit R MajumdarThomas J Marrie
Sep 18, 2004·Medical Care Research and Review : MCRR·Douglas A Conrad, Jon B Christianson
Sep 18, 2004·Medical Care Research and Review : MCRR·Robert TownBryan Dowd
Oct 2, 2004·The New England Journal of Medicine·Martin Roland
Nov 24, 2005·Eye·R J C Bowman

❮ Previous
Next ❯

Citations

Apr 28, 2006·Journal of General Internal Medicine·Catarina I Kiefe, Anne Sales
Mar 26, 2010·American Journal of Respiratory and Critical Care Medicine·Jeremy M KahnUNKNOWN American Thoracic Society Pay-for-Performance Working Group
Sep 3, 2011·Journal of Oncology Practice·Raymond N C KuoMei-Shu Lai
May 21, 2008·Journal of Health Organization and Management·Stephen Buetow
Nov 3, 2006·The New England Journal of Medicine·Meredith B RosenthalArnold M Epstein
Dec 1, 2006·Expert Review of Pharmacoeconomics & Outcomes Research·Constance LiuDavid Litaker
Jun 15, 2007·The New England Journal of Medicine·Takahiro HigashiPaul G Shekelle
Dec 5, 2008·Journal of the American Geriatrics Society·Joseph G Ouslander
Nov 5, 2010·The New England Journal of Medicine·Vahakn B ShahinianScott M Gilbert
May 12, 2016·Journal of Graduate Medical Education·Syed Ahmed HussainSuzanne R White

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved